GDLSK

UPDATE: USTR ANNOUNCES THE MODIFICATION OF A 301 LIST 1 PRODUCT

On June 5, 2020, the U.S. Trade Representative (“USTR”) announced the modification of a China 301 List 1 exclusion as described below:

Original Language Amended Language
Machines for crushing/grinding pills, each valued over $20 but not over $35 (described in statistical reporting number 8479.82.0080) Machines for crushing/grinding pills, each valued not over $35 (described in statistical reporting number 8479.82.0080)

Separately, the USTR continues to seek comments identifying additional medical-care items that should be excluded from China Section 301 tariffs in light of the ongoing COVID-19 outbreak (even if a prior exclusion request on an item has been denied or is pending).  The comment period will remain open until at least June 25, 2020.  Additional information can be found at: https://www.gdlsk.com/ustr-soliciting-comments-on-the-removal-of-china-sec-301-duties-from-additional-medical-care-products/?highlight=medical.

If your business is interested in seeking a refund of past duties paid under Section 301, and/or discussing Section 301 mitigation strategies, please contact our office and speak with one of our attorneys.

mailgoogle_plustwitterFacebookredditlinkedin